New Jersey has joined 42 other states in suing global pharmaceutical company Novartis and its spin-off Sandoz for engaging in ...
More than half of the drugs listed on the new TrumpRx website have a cheaper generic version on the market that can be ...
Generic drugmakers settle inflated prices claim by paying $18 million and adopting antitrust compliance reforms in a decade-long Connecticut lawsuit.
Indian drugmaker Dr Reddy’s Laboratories Ltd. is planning to launch a generic version of Novo Nordisk A/S’s Ozempic in March after the drug’s patent expiry, becoming one of the first firms to capture ...
The Oklahoma attorney general says two pharmaceutical companies agreed to pay $17.85 million to settle allegations of illegally raising prices on generic medications.
Six pharmaceutical companies have applied to make a generic version of semaglutide, and competition will continue to heat up ...
FOX 13 Seattle on MSN
Washingtonians could get money from generic drugs price fixing settlement
Washingtonians who purchased certain generic drugs between 2009 and 2019 could be eligible for compensation.
Lawsuit alleges a 2019 settlement delayed Teva's generic Victoza launch, with plaintiffs seeking unspecified monetary damages ...
Health care workers are changing how they counsel patients. Experts are using our database to support their research. And ...
Arizona Attorney General Kris Mayes announced two settlements of more than $17.85 million with a pair of companies over ...
FDA approves first generic florfenicol–flunixin injectable (nixiFLOR) for bovine respiratory disease
The FDA has approved nixiFLOR, the first generic florfenicol-flunixin injectable, for treatment of bovine respiratory disease and control of associated fever in beef and nonlactating dairy cattle.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results